Skip to content

Clinical trials

Phase 2 Multiple Sclerosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 2 Country / region: United States Clear all

131 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20024
20033
20043
20055
20067
20075
20082
20097
20107
20115
20124
20135
20143
20155
20165
20173
20186
20193
20202
20217
20225
20234
20248
202510
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Recruiting15
Terminated14
Withdrawn8
Unknown status8
Active, not recruiting8
Enrolling by invitation2
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)9
Sanofi6
Biogen5
Novartis Pharmaceuticals4
Johns Hopkins University3
National Institute of Allergy and Infectious Diseases (NIAID)3
University of California, Los Angeles3
University of California, San Francisco3
VA Office of Research and Development3
AbbVie2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis131
Multiple Sclerosis, Relapsing-Remitting23
Multiple Sclerosis, Chronic Progressive13
Fatigue6
Muscle Spasticity5
Recurrence5
Autoimmune Diseases4
Demyelinating Diseases4
Neoplasms3
Neuroinflammatory Diseases3

Trials

Showing 1 to 25 of 131. Each trial links to its page on Pharma Observatory.

31 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.